宋金芝, 孙洁, 金多晨, 邓艳秋. 罗格列酮对三重转基因小鼠认知障碍的干预作用J. 药学学报, 2014,49(6): 807-812.
引用本文: 宋金芝, 孙洁, 金多晨, 邓艳秋. 罗格列酮对三重转基因小鼠认知障碍的干预作用J. 药学学报, 2014,49(6): 807-812.
SONG Jin-zhi, SUN Jie, JIN Duo-chen, DENG Yan-qiu. Rosiglitazone improves learning and memory impairment of 3×Tg miceJ. Acta Pharmaceutica Sinica, 2014,49(6): 807-812.
Citation: SONG Jin-zhi, SUN Jie, JIN Duo-chen, DENG Yan-qiu. Rosiglitazone improves learning and memory impairment of 3×Tg miceJ. Acta Pharmaceutica Sinica, 2014,49(6): 807-812.

罗格列酮对三重转基因小鼠认知障碍的干预作用

Rosiglitazone improves learning and memory impairment of 3×Tg mice

  • 摘要: 观察胰岛素增敏剂罗格列酮对3×Tg小鼠认知障碍的影响。以雄性C57/BL6小鼠分为正常对照组(WT组)和药物干预组(RSG组),取雄性APP/PS1/tau转基因小鼠随机分为模型组(3×Tg模型组)和罗格列酮治疗组(3×Tg+RSG治疗组)。6月龄小鼠成模后,3×Tg+RSG组和RSG组给予罗格列酮(2.5 mg·kg-1·d-1)灌胃治疗8周,其他组给予等量生理盐水;选用Morris水迷宫实验评估小鼠的认知功能,采用蛋白免疫印迹技术检 测小鼠脑内细胞Tau蛋白和NFs蛋白磷酸化水平及糖基化水平。结果显示: 与WT组和RSG组相比,3×Tg模型组的逃避潜伏期和路径长度显著增加,同时明显减少平台所在象限的停留时间和穿越隐匿平台的次数(P <0.05);此外,模型小鼠脑内Tau蛋白和NFs蛋白磷酸化表达水平明显增高而糖基化相关蛋白的表达显著降低(P <0.05);但3×Tg+RSG治疗组在上述行为学和细胞骨架的病理学改变方面有明显的改善(P <0.05)。结果提示: 罗格列酮可以改善3×Tg模型小鼠阿尔茨海默病(AD)样的学习记忆减退和Tau蛋白的过磷酸化表达。

     

    Abstract: This study is to investigate the protective effect of rosiglitazone (RSG) against learning andmemory impairment of APP/PS1/tau transgenic mice.AD mice model was replicated by using 6-month APP/PS1/tau transgenic mice.The learning and memory ability of mice was evaluated by Morris water maze and Western blotting assays was applied to measure the phosphorylation and O-glycosylation of Tau andneurofilaments (NFs) protein.The results demonstrated that RSG could reverse the learning and memory deficits of 3×Tg mice significantly.It was also found that RSG could suppress the hyperphosphorylation of Tau and NFs protein levels and increase the glycosylation expression of Tau and NFs proteins in 3×Tg mice brain.Together, RSG ameliorates cognitive impairments of 3×Tg mice via the alleviation of the hyperphosphorylated Tau and NFs proteins burden in the brain.

     

/

返回文章
返回